A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer

被引:0
|
作者
Abratt, RP
Bezwoda, WR
Goedhals, L
Hacking, DJ
机构
[1] UNIV CAPE TOWN,RONDEBOSCH 7700,SOUTH AFRICA
[2] UNIV WITWATERSRAND,JOHANNESBURG 2050,SOUTH AFRICA
[3] UNIV ORANGE FREE STATE,BLOEMFONTEIN 9301,SOUTH AFRICA
[4] DURBAN ONCOL CTR,DURBAN,SOUTH AFRICA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1086 / 1086
页数:1
相关论文
共 50 条
  • [41] Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer
    Vansteenkiste, J
    Canon, JL
    Riska, H
    Pirker, R
    Peterson, P
    John, W
    Mali, P
    Lahn, M
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 263 - 269
  • [42] Phase II trial of gemcitabine and cisplatin sequentially administered in Asian patients with unresectable or metastatic non-small cell lung cancer
    Poon, D
    Foo, KF
    Chew, L
    Leong, SS
    Wee, J
    Tan, EH
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2006, 35 (01) : 33 - 37
  • [43] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Dürk, H
    Kneba, M
    Dickgreber, N
    Welte, T
    Müller, T
    Scholtze, J
    Graeven, U
    Jasiewicz, Y
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 654 - 660
  • [44] A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
    Vadell-Nadal, C
    Nogué-Aliguer, M
    Fabregat-Mayol, X
    Saigí-Grau, E
    Gallén-Castillo, M
    LUNG CANCER, 2000, 28 (02) : 109 - 115
  • [45] Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study
    Lippe, P
    Tummarello, D
    Monterubbianesi, MC
    Silva, RR
    Giuliodori, L
    Mari, D
    Santo, A
    Pasini, E
    Cetto, GL
    Rossi, D
    Porfiri, E
    Cascinu, S
    Cellerino, R
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 217 - 221
  • [46] A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC)
    Ginopoulos, P
    Mastronikolis, NS
    Giannios, J
    Karana, A
    Siabi, V
    Karvelas, F
    Rathossis, S
    Apostolopoulos, N
    Mastorakou, A
    LUNG CANCER, 1999, 23 (01) : 31 - 37
  • [47] A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer
    Gatzemeier, U
    Manegold, C
    Eberhard, W
    Wilke, HJ
    Chomy, F
    Chomy, P
    Khayat, D
    Blatter, J
    Seeber, S
    Drings, P
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 836 - 838
  • [48] Phase II studies of gemcitabine for non-small cell lung cancer in Japan
    Fukuoka, M
    Takada, M
    Yokoyama, A
    Kurita, Y
    Niitani, H
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : S42 - S46
  • [49] The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study
    Shen, Hua
    Li, Xiao-Dong
    Wu, Chang-Ping
    Yin, Yong-Mei
    Wang, Rong-sheng
    Shu, Yong-Qian
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2011, 27 (01) : 27 - 32
  • [50] Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study
    Piantedosi, F. V.
    Caputo, F.
    Mazzarella, G.
    Gilli, M.
    Pontillo, A.
    D'Agostino, D.
    Campbell, S.
    Marsico, S. A.
    Bianco, A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (05) : 803 - 807